Name | (S) -methyl 5-cyclopropyl-4- ( (1- (1- (3, 5-dichlorophenyl) ethyl) piperidin-4-yl) methoxy) -2-fluorobenzoate |
---|
Description | GDC-0310 is a selective acyl-sulfonamide Nav1.7 inhibitor, with an IC50 of 0.6 nM for hNav1.7[1]. |
---|---|
Related Catalog | |
Target |
hNav1.4:3.4 nM (IC50) hNav1.2:38 nM (IC50) hNav1.6:198 nM (IC50) hNav1.1:202 nM (IC50) hNav1.5:551 nM (IC50) |
In Vitro | GDC-0310 exhibits an EC50 of 1.1 μM in vivo and a Ki of 1.8 nM for Nav1.7[1]. |
In Vivo | GDC-0310 shows substantially improved Nav selectivity and ADME properties[1]. GDC-0310 exhibits t1/2 values of 5 h, 46 h and 4.4 h in rat (5 mg/kg, iv), dog (1 mg/kg, iv) and cynomolgus monkeys (2 mg/kg, iv), respectively[1]. |
References |
Molecular Formula | C25H28Cl2FNO3 |
---|---|
Molecular Weight | 480.3991232 |